Cowen Downgrades Orphazyme A/S (ORPHA:DC) (ORPH) to Market Perform, After Receiving FDA CRL
Go back to Cowen Downgrades Orphazyme A/S (ORPHA:DC) (ORPH) to Market Perform, After Receiving FDA CRL(NASDAQ: ORPH) | Delayed: 0.87 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.87 | 52 Week High | $ | |||
Open | $0.87 | 52 Week Low | $ | |||
Day High | $0.87 | P/E | N/A | |||
Day Low | $0.87 | EPS | $ | |||
Volume | 64,533 |